Brugada syndrome
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Brugada syndrome. This is a channelopathy. It is usually caused by mutations in the SCN5A gene on chromosome 3p. Fully referenced neurology checklist.
Pathology
- This is a channelopathy
- It is usually caused by mutations in the SCN5A gene on chromosome 3p
- The transmission is autosomal dominant
- There are eight types: BS1-BS8
- It usually affects males
- The heart is structurally normal
Clinical features
Locked: subscribe to see this section.
ECG features
Locked: subscribe to see this section.
Drug triggers to avoid
Locked: subscribe to see this section.
Drug triggers preferably avoided
Locked: subscribe to see this section.
Other triggers
Locked: subscribe to see this section.
References
- Sheikh AS, Ranjan K. Brugada syndrome: a review of the literature. Clin Med 2014; 14:482-489.
- Berne P, Brugada J. Brugada syndrome 2012. Circ J 2012; 76:1563-1571.
- Postema PG, Wolpert C, Amin AS, et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm 2009; 6:1335-1341.
- www.brugadadrugs.org
- Omer H, Omer MH, Alyousef AR, Alzammam AM, Ahmad O, Alanazi HA. Unmasking of Brugada syndrome by lamotrigine in a patient with pre-existing epilepsy: A case report with review of the literature. Front Cardiovasc Med 2022; 9:1005952.
- And 2 more. Subscribe to see the full list
